Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Finance & Markets

This gene-based therapeutics stock could nearly triple, analysts say

Three firms initiated coverage of the the gene-based therapeutics company.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at cnbc.com →

More in Finance & Markets

More from Tuesday 18 August →